Department of Medical Microbiology, University of Gondar, Gondar, Ethiopia.
Front Immunol. 2024 Oct 21;15:1472626. doi: 10.3389/fimmu.2024.1472626. eCollection 2024.
Bacterial and viral infections cause a huge burden to healthcare settings worldwide, and mortality rates associated with infectious microorganisms have remained high in recent decades. Despite tremendous efforts and resources worldwide to explore diagnostic biomarkers, rapid and easily assayed indicators for the diagnosis of bacterial and viral infections remain a challenge. B7 homolog 3 (B7-H3), a member of the B7 family of immunoregulatory proteins, is overexpressed in patients with septicemia, meningitis, pneumonia, and hepatitis. Therefore, B7-H3 could be used as a potential clinical indicator and therapeutic target for bacterial and viral infections caused by , , , hepatitis B virus (HBV), viral hemorrhagic septicemia virus (VHSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Moreover, the interplay between infectious microorganisms and B7-H3 and exploration of the functional roles of the B7-H3 molecule could aid in the development of novel strategies for disease diagnosis and immunotherapy.
细菌和病毒感染给全球的医疗保健机构带来了巨大的负担,而与传染性微生物相关的死亡率在最近几十年一直居高不下。尽管全世界都在努力探索诊断生物标志物,但快速且易于检测的细菌和病毒感染诊断指标仍然是一个挑战。B7 同源物 3(B7-H3)是免疫调节蛋白 B7 家族的成员,在败血症、脑膜炎、肺炎和肝炎患者中过度表达。因此,B7-H3 可以作为细菌和病毒感染的潜在临床指标和治疗靶点,这些感染包括、、、乙型肝炎病毒(HBV)、病毒性出血性败血症病毒(VHSV)、呼吸道合胞病毒(RSV)和人类免疫缺陷病毒(HIV)。此外,传染性微生物与 B7-H3 之间的相互作用以及对 B7-H3 分子功能作用的探索,可以帮助开发用于疾病诊断和免疫治疗的新策略。